Dimova Rumyana, Tankova Tsvetalina, Chakarova Nevena
Department of Diabetology, Clinical Center of Endocrinology, Medical University, Sofia, Sofia, Bulgaria
Department of Diabetology, Clinical Center of Endocrinology, Medical University, Sofia, Sofia, Bulgaria.
J Nutr. 2017 Sep;147(9):1607-1615. doi: 10.3945/jn.117.250209. Epub 2017 Aug 2.
Vitamin D is a fat-soluble secosteroid hormone with pleiotropic effects. 1,25-Dihydroxyvitamin D coordinates the biosynthesis of neurotransmitters in the central nervous system, which regulate cardiovascular autonomic function and may explain its putative role in the development of cardiovascular autonomic neuropathy (CAN). CAN is an independent risk factor for mortality in patients with diabetes and prediabetes and is associated with an increased risk of developing type 2 diabetes and cardiovascular disease. Accumulating data indicate the presence of peripheral nerve injury at these early stages of dysglycemia and its multifactorial pathogenesis. Prediabetes is associated with vitamin D insufficiency. Vitamin D is proposed to prevent the progression of glucose intolerance. The putative underlying mechanisms include maintenance of the intracellular calcium concentration, direct stimulation of insulin receptor expression, and enhancement of the insulin response to glucose transporters. Vitamin D exerts a protective effect on peripheral nerve fibers by decreasing the demyelination process and inducing axonal regeneration. The effects of vitamin D supplementation on glucose tolerance and related autonomic nerve dysfunction have been a recent focus of scientific interest. Although well-designed observational studies are available, the causative relation between vitamin D deficiency, glucose intolerance, and CAN is still debatable. One reason might be that interventional studies are unpersuasive with regard to the beneficial clinical effects of vitamin D supplementation. Because of its favorable side effect profile, vitamin D supplementation might represent an attractive therapeutic option for treating the pandemic prevalence of prediabetes and vitamin D deficiency. Vitamin D supplementation can improve glucose tolerance and cardiovascular autonomic function and can thus reduce cardiovascular mortality among subjects with different stages of glucose intolerance and autonomic dysfunction. However, more patient-centered trials on the use of vitamin D supplementation in different conditions are needed.
维生素D是一种具有多效性的脂溶性类固醇激素。1,25-二羟基维生素D协调中枢神经系统中神经递质的生物合成,这些神经递质调节心血管自主功能,并可能解释其在心血管自主神经病变(CAN)发生发展中的假定作用。CAN是糖尿病和糖尿病前期患者死亡的独立危险因素,与2型糖尿病和心血管疾病的发生风险增加相关。越来越多的数据表明,在血糖异常的这些早期阶段存在周围神经损伤及其多因素发病机制。糖尿病前期与维生素D不足有关。维生素D被认为可以预防葡萄糖耐量异常的进展。假定的潜在机制包括维持细胞内钙浓度、直接刺激胰岛素受体表达以及增强胰岛素对葡萄糖转运蛋白的反应。维生素D通过减少脱髓鞘过程和诱导轴突再生,对周围神经纤维发挥保护作用。补充维生素D对葡萄糖耐量和相关自主神经功能障碍的影响是最近科学研究的焦点。尽管有精心设计的观察性研究,但维生素D缺乏、葡萄糖耐量异常和CAN之间的因果关系仍存在争议。一个原因可能是,关于补充维生素D的有益临床效果,干预性研究缺乏说服力。由于其良好的副作用特征,补充维生素D可能是治疗糖尿病前期大流行和维生素D缺乏的一个有吸引力的治疗选择。补充维生素D可以改善葡萄糖耐量和心血管自主功能,从而降低不同阶段葡萄糖耐量异常和自主神经功能障碍患者的心血管死亡率。然而,需要更多以患者为中心的关于在不同情况下使用补充维生素D的试验。